Immunohistochemical Loss of LKB1 Is a Biomarker for More Aggressive Biology in KRAS-Mutant Lung Adenocarcinoma
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-14-3112
Full Text
Open PDFAbstract
Available in full text
Date
March 3, 2015
Authors
Publisher
American Association for Cancer Research (AACR)